Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study-Reference-Cited by-同舟云学术

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

Published:2014-11 Issue:11 Volume:2 Page:879-890
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Castro Mario,Wenzel Sally E,Bleecker Eugene R,Pizzichini Emilio,Kuna Piotr,Busse William W,Gossage David L,Ward Christine K,Wu Yanping,Wang Bing,Khatry Deepak B,van der Merwe René,Kolbeck Roland,Molfino Nestor A,Raible Donald G

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Analysis of sputum cell counts during spontaneous moderate exacerbations of asthma in comparison to the stable phase;Di Franco;J Asthma,2003

2. Eosinophilic airway disorders;Scott;Semin Respir Crit Care Med,2006

3. Tissue and BAL based biomarkers in asthma;Zhang;Immunol Allergy Clin North Am,2007

4. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study;Castro;Am J Respir Crit Care Med,2011

5. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma;Flood-Page;Am J Respir Crit Care Med,2007

Cited by 435 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers and clinical outcomes after tezepelumab cessation;Annals of Allergy, Asthma & Immunology;2024-09

2. Comparative safety of monoclonal antibodies in chronic inflammatory airway diseases (chronic sinusitis with nasal polyposis and asthma): A network meta-analysis;International Immunopharmacology;2024-09

3. Role of IL‐5 in asthma and airway remodelling;Clinical & Experimental Allergy;2024-06-27

4. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis;Annals of the American Thoracic Society;2024-06

5. Precision medicine for severe asthma – Biological targeted therapy;International Immunopharmacology;2024-06